Page last updated: 2024-08-24

fce 23884 and ergoline

fce 23884 has been researched along with ergoline in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buonamici, M; Cervini, MA; Maj, R; Mantegani, S; Rossi, AC	1
Buonamici, M; Caccia, C; Carfagna, N; Carminati, P; Cervini, MA; Fariello, RG; Maj, R; Mantegani, S; Rossi, AC	1
Buonamici, M; Caccia, C; Carfagna, N; Cavanus, S; Fariello, RG; Fornaretto, MG; Mantegani, S; Roncucci, R; Rossi, AC	1
Blanchet, PJ; Chase, TN; de Jong, D; Metman, LV; Mouradian, MM	1

Trials

1 trial(s) available for fce 23884 and ergoline

Article	Year
Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:3 Topics: Aged; Antiparkinson Agents; Carbidopa; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Receptors, Dopamine D1; Receptors, Dopamine D2; Treatment Outcome	1996

Article

Year

Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:3

Topics: Aged; Antiparkinson Agents; Carbidopa; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Receptors, Dopamine D1; Receptors, Dopamine D2; Treatment Outcome

1996

Other Studies

3 other study(ies) available for fce 23884 and ergoline

Article	Year
A new dopamine agonist in dopamine deprived systems: FCE 23884. Neurochemistry international, 1992, Volume: 20 Suppl Topics: Animals; Apomorphine; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Levodopa; Male; Mice; Motor Activity; Reserpine; Time Factors	1992
FCE 23884, substrate-dependent interaction with the dopaminergic system. I. Preclinical behavioral studies. The Journal of pharmacology and experimental therapeutics, 1991, Volume: 259, Issue:1 Topics: Animals; Apomorphine; Behavior, Animal; Callithrix; Dogs; Dopamine Agents; Dopamine Antagonists; Drug Interactions; Ergolines; Female; Macaca fascicularis; Male; Mice; Motor Activity; Rats; Rats, Inbred Strains; Species Specificity	1991
FCE 23884, substrate-dependent interaction with the dopaminergic system. II. Preclinical biochemical studies. The Journal of pharmacology and experimental therapeutics, 1991, Volume: 259, Issue:1 Topics: Adenylyl Cyclases; Animals; Brain; Dopamine; Dopamine Agents; Dopamine Antagonists; Ergolines; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine	1991